A recent panel during the Milken Institute’s Future of Health Summit discussed keeping innovative drugs affordable.
The panel featured:
- Matthew Eyles, president and CEO, America’s Health Insurance Plans;
- Dan Leonard, president and CEO, National Pharmaceutical Council;
- Mark McClellan, director, Duke-Margolis Center for Health Policy; and
- Seema Verma, administrator, Centers for Medicare and Medicaid Services.
The full panel discussion is available to watch on YouTube.